Paulina Rybakowska

Paulina Rybakowska

Auto-generated profile, based on publicly available information

Paulina Rybakowska

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO), Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Avda. de la Ilustración 114, Granada 18016, Spain

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2021 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
AEAnnelies Emmaneel
Annelies Emmaneel
KQKatrien Quintelier
Katrien Quintelier
DSDorine Sichien
Dorine Sichien
PRPaulina Rybakowska
Paulina Rybakowska
CMConcepción Marañón
Concepción Marañón
YSYvan Saeys
Yvan Saeys
In cytometry analysis, a large number of markers is measured for thousands or millions of cells, resulting in high‐dimensional datasets. During the measurement of these samples, erroneous events can occur such as clogs, speed changes, slow uptake of the sample etc., which can influence the downstream analysis and can even lead to false discoveries. As these issues can be difficult to detect manually, an automated approach is recommended. In order to filter these erroneous events out, we created a novel quality control algorithm, Peak Extraction And Cleaning Oriented Quality Control (PeacoQC), that allows for automated cleaning of cytometry data. The algorithm will determine density peaks per channel on which it will remove low quality events based on their position in the isolation tree and on their mean absolute deviation distance to these density peaks. To evaluate PeacoQC's cleaning capability, it was compared to three other existing quality control algorithms (flowAI, flowClean and flowCut) on a wide variety of datasets. In comparison to the other algorithms, PeacoQC was able to filter out all different types of anomalies in flow, mass and spectral cytometry data, while the other methods struggled with at least one type. In the quantitative comparison, PeacoQC obtained the highest median balanced accuracy and a similar running time compared to the other algorithms while having a better scalability for large files. To ensure that the parameters chosen in the PeacoQC algorithm are robust, the cleaning tool was run on 16 public datasets. After inspection, only one sample was found where the parameters should be further optimized. The other 15 datasets were analyzed correctly indicating a robust parameter choice. Overall, we present a fast and accurate quality control algorithm that outperforms existing tools and ensures high‐quality data that can be used for further downstream analysis. An R implementation is available.

1 March 2016 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
BSBarbara M Szczerba
Barbara M Szczerba
PKPaulina Kaplonek
Paulina Kaplonek
NWNina Wolska
Nina Wolska
APAnna Podsiadlowska
Anna Podsiadlowska
PRPaulina D Rybakowska
Paulina D Rybakowska
UDUmesh S S Deshmukh
Umesh S S Deshmukh
Objectives Autoantibodies reactive with Ro52 are often found in sera of patients with Sjögren's syndrome (SS). This study was undertaken to investigate the role of Ro52-induced immune responses in pathogenesis of SS. Methods New Zealand Mixed (NZM) 2758 mice were immunised with Ro52 in alum adjuvant. Control mice were immunised either with maltose-binding protein or injected with alum alone. Mice were monitored for anti-Ro52 antibody, sialoadenitis and pilocarpine-induced salivation. Antibody binding to salivary gland (SG) cells was analysed in vivo and in vitro by immunofluorescence. Sera from immunised mice were passively transferred into untreated or alum injected NZM2758 mice. Results By day 30 post-immunisation, Ro52 immunised mice generated immunoprecipitating anti-Ro52 antibodies and they had the maximum drop in saliva production. Both Ro52 immunised and control mice showed evidence of mild sialoadenitis. However, only Ro52 immunised mice had antibody deposition in their SG. Passive transfer of Ro52-immune sera induced SG dysfunction in recipient mice, only if the recipients were primed with alum. In vitro, antibodies from Ro52-immune sera were internalised by a SG cell line and this uptake was inhibited by cytochalasin D treatment. Conclusions Our data show for the first time that antibodies induced by Ro52 are capable of inducing SG dysfunction, and that this phenomenon is dependent on the activation of innate immunity. The mouse model described in this study implies that autoantibody deposition in the SG might be an important step in the induction of xerostomia and pathogenesis of SS.

26 March 2013 in Journal of Dental Research
Verified
Journal Article
Closed access
PDF file
BSB.M Szczerba
B.M Szczerba
PRP.D Rybakowska
P.D Rybakowska
PDP. Dey
P. Dey
KPK.M. Payerhin
K.M. Payerhin
APA.B. Peck
A.B. Peck
UDU.S. Deshmukh
U.S. Deshmukh
In Sjögren’s Syndrome (SS), inherent glandular defects, autoimmunity, and mononuclear cell infiltration within the salivary glands cause reduced salivation leading to xerostomia. Excessive production of type I interferons (IFN), triggered by environmental and genetic factors, is considered pathogenic in this disorder. However, whether type I IFN production is causative or an outcome of the disease process is not known. To address this question, we introduced a deficiency of interferon alpha receptor 1 ( Ifnar1) into B6. Aec1Aec2 mice, which are known to have the genetic loci necessary for developing a SS-like disorder. This new mouse strain, B6. Aec1Aec2Ifnar1-/-, lacking type I IFN-mediated signaling, was characterized for pilocarpine-induced salivation, the presence of serum autoantibodies, sialoadenitis, and dacryoadenitis. Compared with the B6. Aec1Aec2Ifnar1+/+ (wild-type) mice, the B6. Aec1Aec2Ifnar1-/- (knockout) mice had significantly lower mononuclear cell infiltration in the salivary and lacrimal glands. The knockout mice were completely protected from salivary gland dysfunction. Surprisingly, they had a robust autoantibody response comparable with that of the wild-type mice. These findings demonstrate that, in the absence of type I IFN-mediated signaling, systemic autoantibody responses can be dissociated from glandular pathology. Our study suggests that, in genetically susceptible individuals, the type I IFN pathway can instigate certain features of SS.

4 December 2015 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
NWNina Wolska
Nina Wolska
PRPaulina Rybakowska
Paulina Rybakowska
ARAstrid Rasmussen
Astrid Rasmussen
MBMichael Brown
Michael Brown
CMCourtney Montgomery
Courtney Montgomery
UDUmesh S S Deshmukh
Umesh S S Deshmukh
Objective: Autoantibodies reactive with Ro52 (tripartite motif−containing protein 21 [TRIM21]) are detected in 70% of patients with primary Sjögren's syndrome (SS). TRIM21 belongs to a 34‐member C‐IV family of TRIM proteins. Although autoantibodies against other TRIM proteins within the C‐IV family have been detected in the sera of patients with primary SS, their clinical relevance remains unclear. This study was undertaken to investigate the frequency of anti‐TRIM38 in patients with primary SS and evaluate its association with various clinical measures of the disease.Methods: Serum samples from patients with primary SS (n = 235) and controls (n = 50) were analyzed for reactivity with in vitro−transcribed and −translated 35S‐methionine−labeled TRIM38 protein. The associations of anti‐TRIM38 with various laboratory and clinical measures of primary SS were evaluated. Reactivity of anti‐TRIM38 with different structural domains of TRIM38 was analyzed. Affinity‐purified anti‐TRIM38 antibodies were used to immunoprecipitate TRIM21.Results: TRIM38‐reactive autoantibodies were detected in the sera of 24 of the 235 patients with primary SS and 2 of the 50 controls. Anti‐TRIM38 positivity was significantly associated with the presence of anti‐Ro60, anti‐Ro52, anti‐La, rheumatoid factor, and hypergammaglobulinemia. Clinically, anti‐TRIM38 was associated with significantly higher ocular surface staining scores, lower Schirmer's test scores, and minor labial salivary gland biopsy focus scores of ≥3.0. Anti‐TRIM38 antibodies mainly recognized the cortactin‐binding protein 2 (CortBP‐2; amino acids 128–238) and the B30.2/SPRY (amino acids 268–465) domains on TRIM38. Affinity‐purified antibodies to TRIM38–CortBP‐2 and TRIM38–B30.2/SPRY domains reacted with TRIM21.Conclusion: Our data demonstrate that anti‐TRIM38 specificity arising in a subset of patients with primary SS is associated with increased severity of the disease.

31 October 2022 in STAR Protocols
Verified
Journal Article
Open access
PRPaulina Rybakowska
Paulina Rybakowska
SGSofie Van Gassen
Sofie Van Gassen
JMJordi Martorell Marugán
Jordi Martorell Marugán
KQKatrien Quintelier
Katrien Quintelier
YSYvan Saeys
Yvan Saeys
CMConcepción Marañón
Concepción Marañón
Mass cytometry (MC) is a powerful large-scale immune monitoring technology. To maximize MC data quality, we present a protocol for whole blood analysis together with an R package, Cyto Quality Pipeline (CytoQP), which minimizes the experimental artifacts and batch effects to ensure data reproducibility. We describe the steps to stimulate, fix, and freeze blood samples before acquisition to make them suitable for retrospective studies. We then detail the use of barcoding and reference samples to facilitate multicenter and multi-batch experiments.

18 October 2020 in Cytometry Part A
Verified
Journal Article
Closed access
PDF file
PRPaulina Rybakowska
Paulina Rybakowska
CBCatalina Burbano
Catalina Burbano
SGSofie Van Gassen
Sofie Van Gassen
NVNieves Varela
Nieves Varela
RARocío Aguilar-Quesada
Rocío Aguilar-Quesada
CMConcepción Marañón
Concepción Marañón